Safety of an Inactivated SARS-CoV-2 Vaccine (CoronaVac) in Children and Adolescents
Clinical trial NCT04884685 · COMPLETED
Trial details
- NCT number
- NCT04884685
- Sponsor
- Sinovac Life Sciences Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-03
- Primary completion
- 2021-08-01
- Enrollment
- 500
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.